From: A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain
PTM events
P-value
adjusted P-value
pS198
0.0007346
0.003306
pS199
0.0000003316
0.000005968
pT231
0.001081
0.003891
pS416
0.0004662
0.002797
pS422
0.00004812
0.0004331